PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for August 12, 2009 Subscribe to this News Feed    
 

Quorum Review IRB Launches New Public Website

Quorum's renovated website is designed with one goal - improved usability. The new website features intuitive navigation that makes it easy for users to access a wealth of information.

Seattle, WA (PRWEB) August 12, 2009 -- On May 21, 2009, Quorum Review IRB, an accredited ethics review board, launched a redesigned website at its URL of www.QuorumReview.com. Quorum's renovated website is designed with one goal - improved usability. The new website features intuitive navigation that makes it easy for users to access a wealth of information.

Quorum's website now utilizes modern coding techniques such as site wide Google-search and a depreciating search function to locate forms. Each page includes an improved navigation bar to help users locate content. "Our new website reflects Quorum's commitment to use cutting edge technology to protect participants and support our researchers," says Cami Gearhart, CEO of Quorum Review.

The new Quorum website also provides expanded content. The website guides researchers through the steps of the ethics review process with background information, links to all applicable forms, and sets of Frequently Asked Questions. Website users also can find information on Quorum's wide array of service offerings, such as the review of publicly funded studies, exemption determinations, in-house translations, working with institutions, pre-review services and training.

Many of the website updates are based on feedback from website users. Usability testing was conducted prior to the implementation of the redesigned website to ensure that information on the site could be quickly and easily located. "We're pleased that the new website provides users easy access to information for selecting an IRB and working with Quorum Review," says Arri Burgess, Director of Customer Relations.

ABOUT QUORUM REVIEW
Quorum Review is an independent ethics review board that is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations, guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.    

Quorum's best-in-class service and support includes 3 protocol board meetings a week, daily amendment board meetings, 24 hour site review turnaround, 36 hour amendment review turnaround, and a secure web portal for online submissions, downloads and submission status review. Quorum can review studies in the US and Canada, review federally funded studies and has a specially designated Phase I study management team.

For information about Quorum Review services:
customerrelations(at)quorumreview.com
www.quorumreview.com

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3VtbS1Qcm9mLVpldGEtSG9yci1Mb3ZlLUNvdXAtWmVybw==

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Arri Burgess
Quorum Review IRB
206-436-3244
Email us Here
Courtney Scott
206-436-3222
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move